Chimerix
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Chimerix and other ETFs, options, and stocks.About CMRX
Chimerix, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of pharmaceutical products. Its portfolio includes Brincidofovir for the treatment of adenovirus, cytomegalovirus, and smallpox.
CEOMichael T. Andriole
CEOMichael T. Andriole
Employees72
Employees72
HeadquartersDurham, North Carolina
HeadquartersDurham, North Carolina
Founded2000
Founded2000
Employees72
Employees72
CMRX Key Statistics
Market cap85.63M
Market cap85.63M
Price-Earnings ratio-1.02
Price-Earnings ratio-1.02
Dividend yield—
Dividend yield—
Average volume246.20K
Average volume246.20K
High today$0.9753
High today$0.9753
Low today$0.905
Low today$0.905
Open price$0.95
Open price$0.95
Volume319.00K
Volume319.00K
52 Week high$1.57
52 Week high$1.57
52 Week low$0.88
52 Week low$0.88
CMRX News
Yahoo Finance 15h
Chimerix, Inc. Q1 2024 Earnings Call Transcript - Yahoo FinanceChimerix, Inc. (NASDAQ:CMRX) Q1 2024 Earnings Call Transcript May 1, 2024 Chimerix, Inc. misses on earnings expectations. Reported EPS is $-0.25 EPS, expectati...
TipRanks 2d
Chimerix Releases Updated Corporate Presentation for InvestorsThe latest update is out from Chimerix (CMRX). On May 1, 2024, the Company released an updated corporate presentation for use in discussions with investors and...
Analyst ratings
100%
of 7 ratingsBuy
100%
Hold
0%
Sell
0%